More Than Two Years Later, Netflix Continues to Pay Off for Carl Icahn

More Than Two Years Later, Netflix Continues to Pay Off for Carl Icahn

The impressive earnings results Netflix posted at market close yesterday resulted in major gains today. Altisource Portfolio Solutions (NASDAQ:ASPS) and Seventy Seven Energy (NYSE:SSE) also ended the day well in the green. In the red this Wednesday are Eldorado Gold Corp. (NYSE:EGO), Intrexon Corp. (NYSE:XON) and Kite Pharma Inc. (NASDAQ:KITE).

Sign up for our free daily newsletter

Gates Capital Returns 32.7% Tries To Do “Fewer Things Better”

Gates Capital Management's Excess Cash Flow (ECF) Value Funds have returned 14.5% net over the past 25 years, and in 2021, the fund manager continued to outperform. Due to an "absence of large mistakes" during the year, coupled with an "attractive environment for corporate events," the group's flagship ECF Value Fund, L.P returned 32.7% last Read More

Netflix Soars

Netflix soared +17.34% today after posting better-than-expected earnings and strong international growth. The internet streaming service has been one of Carl Icahn’s best investments in recent years, its price more than tripling since he first invested in 2012 (he’s already cashed in quite a bit). Fellow billionaire George Soros initiated a stake in the company in the third quarter of last year.


Altisource Portfolio Solutions hit market close posting a +16.23% gain for the day, though it’s still lost -48.02% over the past month. Today, Leon Cooperman made regulatory filings disclosing an increased stake in the stock.

Chesapeake Energy spinoff Seventy Seven Energy rallied +12.24% today, and yesterday, an issue of its bonds rose +2% against their face value. The stock has tumbled -80.65% since splitting off in June.

Eldorado Gold Plummets on Disappointing Forecast

Eldorado Gold plummeted -20.18% after issuing a disappointing forecast for 2015. Ray Dalio’s Bridgwater Associates picked up a stake in the company in late 2012 and as of the third quarter of 2014 holds 644,000 EGO shares.

Intrexon tumbled -12.32% today, just a day after announcing an underwritten public offering of up to $150 million of its shares in company stocks. As of their most recent 13F filings, both Dan Loeb and David Einhorn have positions in the synthetic biology company.

Kite Pharma ended the day down -9.22%, putting its five-day loss at -20.21%. Despite its recent dip, however, the stock is up +88.31% over the past three months. George Soros has made a nice gain on this one.


Updated on

No posts to display